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Summary
Aim: To improve the understanding of factors that 
influence adenosine deaminase (ADA) activity in large 
peri cardial effusions.
Methods: A prospective study was carried out at 
Tygerberg Academic Hospital, South Africa. Patients 
underwent echocardiographically guided pericardiocen-
tesis. ADA activity, as well as biochemistry, haematolo-
gy, cytology, and in some cases, histology, were deter-
mined. Human immunodeficiency virus (HIV) status 
was assessed in all patients.
Results: Two hundred and thirty-three patients pre-
sented to Tygerberg Hospital with large pericardial 
effusions requiring pericardiocentesis. Tuberculous peri-
carditis accounted for 162 effusions (69.5%). An ADA 
cut-off level of 40 U/l resulted in a test sensitivity, 
specificity, positive predictive value (PPV), negative 
predictive value (NPV) and diagnostic efficiency of 
84.0%, 80.0%, 91.0%, 66.0% and 83.0%, respectively. 
Pericardial exudates with an ADA activity ≥ 40 U/l were 
associated with increased total leukocyte and neutro -
phil counts. Patients with tuberculous pericarditis and 
ADA ≥ 40 U/l also had increased lymphocyte counts. 
Pericardial ADA activity < 30 U/l was associated with 
severe depletion of CD4 cell counts in HIV-positive 
patients. ADA levels were higher in cases with histologi-
cal evidence of granulomatous inflammation than in 
cases with serofibrinous pericarditis.
Conclusions: An ADA cut-off level of 40 U/l results in 
best diagnostic test results. ADA production appears 
to be influenced by factors associated with the anti-
tuberculous immune response.
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Tuberculosis (TB) is the most important cause of serious 
pericardial disease in sub-Saharan Africa, and this is likely 
to worsen with the increase in the human immunodeficiency 
virus (HIV) epidemic.1-3 It is often difficult to establish 
a definite diagnosis in tuberculous pericarditis, and a 
number of diagnostic tests are required to support a clinical 
diagnosis.3,4 In countries where TB is endemic, the increase 
in adenosine deaminase (ADA) activity observed in the 
pericardial fluid of patients with TB has been used to 
establish the diagnosis of tuberculous pericarditis.4-7
ADA is a polymorphic enzyme that is involved in purine 
metabolism. It catalyses the deamination of adenosine 
and deoxyadenosine to produce inosine and deoxyinosine, 
respectively.8 It also plays a role in the differentiation 
of lymphoid cells9,10 and the maturation of monocytes to 
macrophages.11 The presence of ADA in pericardial and 
other body fluids reflects the activity of the cellular immune 
response in the respective compartments and in particular, 
the activation of T lymphocytes and macrophages.12,13
Aim
In order to improve the understanding of factors that 
influence the ADA activity in large pericardial effusions, 
pericardial ADA results obtained from a prospective study 
of patients who required therapeutic pericardiocentesis were 
analysed and, where possible, correlated with pericardial 
leukocyte counts, peripheral CD4+ lymphocyte counts and 
histopathological features. 
Materials and methods
A prospective study was carried out at Tygerberg Academic 
Hospital, South Africa. A total of 233 consecutive patients 
presenting with large pericardial effusions to the Echo-
cardiography Unit between February 1995 and June 2001 
were enrolled and followed up for a minimum of 12 months. 
The study was approved by the Ethics Committee of 
Stellenbosch University. At the time of enrollment, patients 
underwent echocardiographically guided pericardiocentesis 
followed by daily intermittent catheter drainage. 
Pericardial fluid was sent for biochemistry, haematology 
and cytology. If an aetiological diagnosis could not be made
within seven days, a pericardial biopsy was performed under 
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general anaesthesia. The biopsy tissue was sent (in formalin) 
for histopathological evaluation. Each piece of tissue was 
sectioned and stained with haematoxylin and eosin (H&E), 
as well as with Ziehl-Neelsen (ZN) stain. Where applica-
ble, patients were started on a six-month course of anti-
tuberculous therapy. HIV-positive individuals were treated 
with daily co-trimoxazole and referred to the Infectious 
Diseases Clinic for staging and management of their HIV. 
ADA activity (U/l) was determined in all pericardial fluid 
specimens according to the method described by Giusti.14 
This is a calorimetric method based on measurement by 
Berthelot’s reaction of the formation of ammonia, which is 
produced when ADA acts on excess adenosine. One unit 
of ADA is defined as the amount of enzyme required to release 
one µmole of ammonia per minute from adenosine at standard 
assay conditions. The enzyme is stable for at least 24 hours 
at 25˚C, seven days at 4˚C and three months at –20˚C.15,16
The final diagnosis was made according to pre-deter-
mined criteria. Tuberculous pericarditis was diagnosed if 
the patient met one or more of the following criteria: (i) 
identification of Mycobacterium tuberculosis in pericardial 
fluid or biopsy specimen by ZN stain and/or by TB culture, 
(ii) histological evidence of necrotising, granulomatous 
inflammation of the pericardium, (iii) positive ZN smear 
and/or TB culture and/or histological evidence of TB from 
one or more extracardiac sites, in the absence of any other 
cause for pericardial effusions, and/or (iv) clinical features 
of tuberculous pericarditis associated with a sustained posi-
tive response to anti-tuberculous therapy in the absence of 
any other cause for pericardial effusion. 
Non-tuberculous pericardial effusions were defined as 
those with no histological evidence of TB, that were 
effusion/sputum ZN and TB culture negative, and where 
a definite alternative diagnosis was established.17 These 
included malignant effusions; effusions associated with con-
nective tissue disease such as systemic lupus erythematosus 
(SLE), mixed connective tissue disease, systemic sclerosis 
and rheumatoid arthritis; uraemic pericarditis; septic pericar-
ditis; and post-traumatic/post-surgical pericardial effusions. 
Statistical analysis
Statistical analysis was done with the Kruskall-Wallis one-
way ANOVA, the Bonferroni two-way ANOVA and Chi-
square tests. A p-value < 0.05 was considered statistically 
significant. The correlation between two variables was plot-
ted on a scatter plot and Spearman rank coefficients were 
used to express the relationship. The significance of the 
correlation was denoted by a p-value < 0.05. All statistical 
analyses were done using Statistica version 6.0. 
The utility of determining ADA activity as a diagnostic 
tool for pericardial TB was evaluated by calculating sensitiv-
ity, specificity, positive predictive value (PPV), negative 
predictive value (NPV) and diagnostic efficiency expressed 
as a percentage. Sensitivity was defined as TP/(TP + FN) × 
100; specificity was defined as TN/(TN + FP) × 100; PPV 
was defined as TP/(TP + FP) × 100; NPV was defined as 
TN/(TN + FN) × 100, and diagnostic efficiency was defined 
as (TP + TN)/(TP + FP + TN + FN) × 100, where TP = true 
positive, TN = true negative, FP = false positive and FN = 
false negative. These were compared by means of relative 
operating characteristic (ROC) curves18 and the cut-off value 
that maximised the true positive rate was selected.
Results 
During the study period, 233 patients presented to Tygerberg 
Hospital with large pericardial effusions requiring pericar-
diocentesis. This included 101 (43.0%) females and 132 
(67.0%) males. Tuberculous pericarditis accounted for 162 
effusions (69.5%), malignant effusions for 22 (9.4%), effu-
sions associated with connective tissue diseases for 12 
(5.2%), septic pericarditis for five (2.1%), and ‘other’ 
effusions for 32 (13.7%). In total, 84 patients were HIV 
positive, including 81 patients who had pericardial TB 
(50.0% of TB patients). The mean (SD) age of the HIV-
positive tuberculous group was significantly lower (p < 
0.05) than that of the HIV-negative tuberculous patients 
[31.9 (8.4) (range 13–55) years and 41.6 (14.1) (range 
13–85) years, respectively].
‘Definite’ TB (histological and/or microbiological evi-
dence for TB) was diagnosed in 118 (73.0%) of the 162 
patients classified as having tuberculous pericarditis. This 
included 91 patients with pericardial effusions with a posi-
tive TB culture, 13 patients with a pericardial biopsy that 
was diagnostic of TB, and 32 patients with a positive 
ZN smear and/or TB culture and/or histology in one or 
more extracardiac sites. A number of patients had TB 
demonstrated in more than one site. ‘Probable’ TB (clinical 
diagnosis in absence of histological and/or microbiological 
evidence for TB) was diagnosed in a further 44 patients. 
Eleven of the 162 tuberculous patients had been on anti-
tuberculous therapy for more than 48 hours at the time 
of pericardial aspiration; all of them were HIV negative, 
including four patients with ‘definite’ TB and seven patients 
with ‘probable’ TB. 
The corresponding median (range) ADA activity for 
patients with tuberculous (HIV negative) pericardial effu-
sions, tuberculous (HIV positive) pericardial effusions, 
malignancy, septic pericarditis, connective tissue disease and 
other non-tuberculous pericardial effusions are presented in 
Table I. Various levels of pericardial fluid ADA activity 
were evaluated as a cut-off level for the diagnosis of 
pericardial TB and, based on ROC curves,18 the best results 
were obtained at a cut-off level of 40 U/l.
In total, 13 (out of 71) patients with non-tuberculous effu-
sions had levels of ADA activity exceeding 40 U/l. These 
false positives included patients with septic pericarditis (n = 
4; corresponding ADA activities of 49.1 U/l, 55.6 U/l, 
138.6 U/l and 165.8 U/l, respectively), SLE (n = 1; cor-
responding ADA 49.0 U/l), rheumatoid arthritis (n = 1; 
corresponding ADA 65.3 U/l), post-traumatic pericarditis 
(n = 1; corresponding ADA 47.5 U/l), pericarditis of 
unknown origin (n = 1; corresponding ADA 50.4 U/l), non-
haematological malignancies (n = 3); and haematological 
malignancies (n = 2). The malignancies included pericardial 
adenocarcinoma (ADA 47.5 U/l), squamous cell carcinoma 
(ADA 46.0 U/l), undifferentiated carcinoma (ADA 50.9 
U/l), lymphoblastic T-cell lymphoma (ADA 166.0 U/l) and 
chronic myelomonocytic leukaemia (ADA 102.5 U/l). 
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Using the cut-off level of 40 U/l resulted in 22 false-
negative pericardial effusions. Twelve of these occurred 
in HIV-negative and 10 in HIV-positive patients, respec-
tively. Nine of the 12 HIV-negative patients were on 
anti-tuberculous therapy at the time of pericardiocentesis, 
whereas no HIV-positive patient was on active anti-tuber-
culous therapy at the time of pericardial aspiration. An 
additional two HIV-negative patients were also on anti-
tuberculous medication; in these two the corresponding 
pericardial ADA activity levels were 75.0 U/l and 81.0 
U/l, respectively. The corresponding median (range) ADA 
activity for HIV-negative TB patients on anti-tuberculous 
therapy, HIV-negative TB patients not on anti-tuberculous 
therapy, HIV-positive TB patients, and patients with non-
tuberculous pericardial effusions is presented in Table II. 
In three patients with tuberculous pericarditis, no specific 
cause could be identified for the low pericardial ADA 
activity. The corresponding ADA activity for these three 
cases was 22.0 U/l, 24.0 U/l and 34.0 U/l, respectively. 
After exclusion of all patients on anti-tuberculous therapy 
and all those categorised as pericarditis of unknown cause, 
an ADA activity cut-off level of 40 U/l resulted in the cor-
responding sensitivity, specificity, PPV, NPV and diagnostic 
efficiency of 90.0%, 74.0%, 90.0%, 76.0% and 86.0%, 
respectively. 
In tuberculous pericardial effusions, lymphocytes domi-
nated the inflammatory cellular infiltrate. The corresponding 
median (range) pericardial lymphocyte/neutrophil ratios for 
tuberculous (HIV negative), tuberculous (HIV positive) and 
non-tuberculous pericardial effusions were 2.7 (0.2–74.0) 
U/l, 1.9 (0.1–7.5) U/l and 0.4 (0.1–2.2) U/l, respectively. 
The corresponding correlation (Spearman rank) between 
pericardial total leukocyte, neutrophil, lymphocyte and 
macrophage counts were r = 0.30 (p = 0.07); r = 0.25
(p = 0.13); r = 0.31 (p = 0.07); and r = 0.14 (p = 0.59), 
respectively. In the tuberculous pericardial exudates, the 
corresponding median (range) pericardial fluid leukocyte, 
neutrophil and lymphocyte counts were significantly higher 
in effusions with ADA activity ≥ 40 U/l than in pericardial 
effusions with ADA levels < 40 U/l (p = 0.03, p = 0.02 and
p = 0.03, respectively), whereas in non-tuberculous effu-
sions, only the total leukocyte and neutrophil counts were 
higher in high ADA effusions than in low ADA effusions, 
as summarised in Table III. 
In the HIV-positive tuberculous group, the correlation 
between pericardial ADA activity and peripheral blood CD4 
cell counts was not significant (r = 0.17; p = 0.20). However, 
at very low CD4+ cell counts there was a tendency towards 
low levels of ADA activity. The corresponding median 
(range) CD4 cell counts for patients with pericardial ADA 
activity < 30 U/l, pericardial ADA activity < 40 U/l and peri-
cardial ADA activity ≥ 40 U/l were 59.0 (6.0–115.0) cells/µl, 
183.0 (6.0–578.0) cells/µl and 219.0 (25.0–1 006.0) cells/µl, 
respectively. In the HIV-negative tuberculous patients and 
the non-tuberculous patients the corresponding correlation 
between pericardial ADA activity and peripheral CD4 cell 
counts was r = –0.89 (p = 0.04) and r = –0.42 (p = 0.57), 
respectively. 
A total of 25 pericardial biopsies were performed in 
patients from the tuberculous group; five of these patients 
were HIV positive. Fifteen biopsies demonstrated granulo-
ma tous inflammation; 12 of these were accompanied by 
caseating necrosis. A biopsy specimen from an HIV-positive 
patient resembled acute purulent pericarditis; a diagnosis of
pericardial TB was based on the presence of numerous acid-
fast bacilli accompanied by a positive pericardial fluid TB
culture, a negative Gram stain and a negative culture for non-
tuberculous bacteria. The remaining nine biopsies demon-
strated no characteristic histomorphological features of TB. 
They were categorised as serofibrinous pericarditis (n = 6) 
and fibrotic pericarditis (n = 3). For patients with pericardial 
 TABLE I. PERICARDIAL ADA ACTIVITY IN VARIOUS DIAGNOSTIC
SUBGROUPS OF PERICARDITIS
  Adenosine deaminase activity (U/l)    
Diagnostic groups n Mean 95% confidence intervals p
Tuberculous pericarditis 
  HIV negative  75 79.6 69.7–89.5 
  HIV positive  76 76.3 66.6–86.0 1.00
Malignant pericardial effusion 20 39.3 20.0–58.6 0.007
Uraemic pericarditis 9 21.1 –7.7–49.8 0.004
Septic pericarditis 4 102.3 59.2–145.4 1.00
Connective tissue disease 8 31.1 0.6–61.6 0.06 
Other pericardial effusions 20 30.0 10.7–49.3 0.0002
HIV: human immunodeficiency virus
p-value established by Bonferroni test, notifying difference between diagnostic group from 
HIV-negative tuberculous pericarditis.
 TABLE II. PERICARDIAL ADA ACTIVITY IN VARIOUS DIAGNOSTIC
GROUPS OF PERICARDITIS
  Adenosine deaminase activity (U/l)    
Diagnostic groups n Mean 95% confidence intervals p
Tuberculous pericarditis 
  HIV negative (not on ATC) 64 88.9 78.5–99.3 
  HIV negative (on ATC) 13 24.9 0.0–50.1 0.0000039
  HIV positive  78 76.3 66.6–86.0 0.48
Non-tuberculous pericarditis 61 36.6 25.9–47.3 0.001
HIV: human immunodeficiency virus
ATC: anti-tuberculous chemotherapy
p-value established by Bonferroni test, notifying difference between diagnostic group from 
HIV-negative tuberculous pericarditis not on ATC.
 TABLE III. RELATIONSHIP BETWEEN PERICARDIAL LEUKOCYTES AND 
PERICARDIAL ADA ACTIVITY
Subgroups n ADA < 40 U/l n ADA ≥ 40 U/l p
Tuberculous effusions
Pericardial total leukocytes 6 1220 (470–2210) 25 2580 (400–10260) 0.03
Pericardial neutrophils 6 53 (15–88) 24 918 (158–7377) 0.02
Pericardial lymphocytes  6 721 (180–1768) 24 1140 (99–2654) 0.03
Non-tuberculous effusions
Pericardial total leukocytes 6 1655 (220–360) 5 4341 (80–24140) 0.02
Pericardial neutrophils 6 812 (103–1787) 5 2843 (24–19336) 0.04
Pericardial lymphocytes 6 584 (51–1520) 5 260 (56–1497) 0.18 
ADA: adenosine deaminase activity
Results expressed as median (range) cells/µl
p-value established by two-way ANOVA. 
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TB, the median (range) ADA levels for granulomatous, 
purulent, serofibrinous and fibrotic pericarditis were 110.0 
(41.0–304.0) U/l, 101.0 U/l, 68.0 (1.3–166.0) U/l, and 
101.0 (34.0–166.0) U/l, respectively. For the HIV-positive 
TB patients, the median (range) ADA levels for granulo-
matous, purulent and serofibrinous pericarditis were 93.0 
(78.0–108.0) U/l, 101.0 U/l and 74.0 (51.0–97.0) U/l, respec-
tively. These differences were statistically non-significant. 
Discussion
In South Africa, the majority of patients presenting with 
large pericardial effusions have pericardial TB.19,20 The 
present study confirms that pericardial TB is responsible for 
approximately 70% of the cases of large pericardial effu-
sions seen at Tygerberg Academic Hospital in the Western 
Cape of South Africa. Fifty per cent of all tuberculous 
effusions were seen in HIV-positive individuals. 
We documented high levels of ADA in tuberculous 
pericardial effusions. In HIV-negative TB patients the most 
notable cause for low pericardial ADA levels was the 
con comitant use of anti-tuberculous chemotherapy at the 
time of pericardiocentesis, suggesting that anti-tuberculous 
therapy influences ADA activity by one or more of the fol-
lowing mechanisms: (i) anti-tuberculous therapy increases 
the metabolic breakdown of ADA (possibly by rifampicin’s 
effect on hepatic metabolism), and/or (ii) anti-tuberculous the-
rapy suppresses ADA activity directly, and/or (iii) anti-tuber-
culous therapy affects the cell turnover of pericardial macro-
phages and T lymphocytes, thereby reducing ADA levels.
The median ADA activity was not significantly lower 
in HIV-positive than in HIV-negative TB patients and the 
correlation between peripheral CD4+ lymphocyte counts 
and pericardial ADA activity levels was non-significant. 
However, a relationship between severe peripheral CD4+ 
lymphocyte depletion and low ADA levels was noted. Seven 
of the 10 HIV-positive patients with low ADA tuberculous 
effusions (ADA activity < 40 U/l) had corresponding CD4 
cell counts < 200 cells/µl. The difference between CD4 
cell counts associated with pericardial ADA activity < 40 
U/l and pericardial ADA activity ≥ 40 U/l was minimal 
[corresponding counts being 183.0 (6.0–578.0) cells/µl 
and 219.0 (25.0–1006.0) cells/µl, respectively (p = 0.8)]. 
However, in the group of tuberculous patients with pericar-
dial ADA activity < 30 U/l, the corresponding median 
(range) CD4 cell count of 59.0 (6.0–115.0) cells/µl was 
significantly decreased (p = 0.04). These results suggest 
that severe CD4+ lymphocyte depletion may result in low 
ADA activity levels, probably by impeding the CD4+ 
lymphocyte-dependent cellular immune response against 
mycobacterial antigens in the pericardial space. 
The inverse relationship between peripheral CD4+ cell 
counts in HIV-negative tuberculous patients can be explained 
by the recruitment of peripheral CD4+ cells into the 
pericardial space. Pericardial CD4+ cell counts were not 
determined, however, to corroborate this theory.
Pericardial exudates with an ADA activity ≥ 40 U/l were 
associated with higher total leukocyte and higher neutrophil 
counts than pericardial effusions with ADA activity < 40 
U/l. In the group of patients with tuberculous pericarditis, 
pericardial exudates with ADA activity ≥ 40 U/l were 
also characterised by higher lymphocyte counts than tuber-
culous exudates with ADA activity < 40 U/l. Pericardial 
macrophage counts were available for only a minority of 
effusions; no specific correlation between ADA levels and 
macrophage counts could be demonstrated in these cases. 
Pericardial neutrophil counts were lower for tuberculous 
effusions than for non-tuberculous effusions, whereas medi-
an ADA activity was significantly higher in tuberculous than 
in non-tuberculous exudates. This implies that in tuberculous 
effusions, lymphocytes (and possibly macrophages) play 
the major role in the production and release of ADA, 
which supports data from tuberculous pleural exudates.21 It 
has been demonstrated that lymphocytes and macrophages 
contain similar levels of ADA activity, and that this is 
much higher than in other cell types or tissues.22 Due to 
insufficient pericardial macrophage counts, our study does 
not add additional information on the potential contribution 
of macrophages to the ADA activity in tuberculous exudates. 
Tuberculous exudates with ADA activity < 40 U/l were 
accompanied by significantly lower pericardial neutrophil 
counts than effusions with ADA activity ≥ 40 U/l, suggest-
ing that neutrophils also contribute to ADA activity. In non-
tuberculous effusions, neutrophils are probably the major 
source of ADA, although lymphocytes may also contribute.23 
However, significantly higher pericardial leukocyte counts 
are ‘required’ to produce similar levels of ADA activity. 
In the present study, the contribution of neutrophils 
to ADA activity in non-tuberculous effusions was most 
notable in the case of septic pericarditis and in effusions 
associated with malignancies. A differential white cell count 
and cytological analysis of the pericardial fluid is therefore 
mandatory in patients with large pericardial effusions to 
exclude these two conditions, which are characterised by a 
predominance of pericardial fluid neutrophils and malignant 
cell lines, respectively. 
In this study, ADA levels tended to be higher in cases that 
showed histological evidence of granulomatous inflamma-
tion than in cases with serofibrinous pericarditis, suggesting 
that the cells involved in the development and maintenance 
of granulomatous lesions (mainly activated macrophages 
and T lymphocytes) were also responsible for the elevated 
ADA activity in the pericardial fluid, as has been previously 
suggested.12,13 
Conclusion
Our study adds considerable support to the use of ADA 
activity as a diagnostic tool for the diagnosis of pericardial 
TB, and gives some insight into its use in areas characterised 
by a high prevalence of TB and HIV co-infection. Based 
on ROC curves,18 the best results in the present study 
were obtained at a cut-off level of 40 U/l. In HIV-positive 
patients, a correlation between severe CD4 lymphocyte 
depletion and low ADA levels was observed, whereas in 
the HIV-negative patients the most notable cause for low 
ADA levels was the use of anti-tuberculous chemotherapy 
at the time of pericardiocentesis. This suggests that anti-
tuberculous therapy influences the ADA activity in patients 
infected with TB, possibly by affecting the metabolism of
ADA and/or by suppressing mycobacterial replication, there-
by indirectly affecting lymphocyte and macrophage activity. 
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Histopathological analysis of pericardial tissue demon-
strated that granulomatous pericarditis was associated with 
higher ADA activity than serofibrinous pericarditis. The 
contribution of CD4 cells in the delayed hypersensitivity 
response and protection against TB is well described, 
including the interaction with macrophages that spearheads 
the protective immune response against TB.24 Our data 
suggest that factors influencing the anti-tuberculous immune 
response also affect ADA production.
A number of non-tuberculous diseases may also present 
with elevated pericardial ADA activity, most importantly 
septic pericarditis and effusions associated with malignan-
cies. A differential white cell count and cytological analysis 
of the pericardial fluid is therefore mandatory to exclude 
these two conditions, which are characterised by a predomi-
nance of pericardial fluid neutrophils and malignant cell 
lines, respectively. 
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